Religare Enterprises Limited has informed the Exchange regarding 'Updates'.
RELIGARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board, which met on August 12, 2025, approved Religare's unaudited financial results for Q1 FY26 (quarter ended June 30, 2025) on both standalone and consolidated basis. On a standalone basis, total revenue fell sharply to Rs. 310.32 lakhs from Rs. 813.42 lakhs a year ago, though net loss narrowed to Rs. 614.83 lakhs from Rs. 1,584.31 lakhs. On a consolidated basis, revenue rose to Rs. 1,87,168.97 lakhs (vs Rs. 1,71,443.19 lakhs YoY), but net profit dropped sharply to Rs. 817.27 lakhs (vs Rs. 2,681.20 lakhs), translating to a basic EPS of Rs. 0.31. The board also extended statutory auditor J C Bhalla & Co's term for two more years (FY26 and FY27), appointed PI & Associates as secretarial auditors for five years (FY26–FY30), and named Mr. Pratul Gupta as Interim CFO. Additionally, Rs. 10 lakh Letters of Assurance each were approved for two non-operational subsidiaries – MIC Insurance Web Aggregator and Religare Care Foundation. The RBI restriction on declaring dividends (from December 2019) remains in place.
Mixed signals for shareholders: while the standalone loss has narrowed, the sharp fall in consolidated profit and persistent losses at the parent level may weigh on sentiment. However, recent positive developments – RBI lifting the Corrective Action Plan on subsidiary Religare Finvest, Delhi High Court quashing the 'fraud' tag on RFL, and the shareholders' approval of a ~Rs. 1,500 crore preferential warrant issue – could support the stock if execution remains on track.